Christine K.
- Country
- Germany
- Department
- na
Research Overview
- Phase III Study of RO7795068 for Weight Management in Adults With Obesity or Overweight Without Type 2 Diabetes
- Phase III Study of RO7795068 in Adults With Obesity or Overweight and Type 2 Diabetes
- Phase III Randomized Open‑Label Trial Evaluating Elecoglipron Versus Oral Semaglutide for Glycemic Control in Adults with Type 2 Diabetes Mellitus
Data & Insights
Has run more than one trial at 254 of 850 partner sites.
Specializations
Cardiovascular and Metabolic Health
The investigator specializes in treating hypercholesterolemia and cardiovascular conditions, with particular focus on innovative lipid-lowering therapeutic approaches. Their research encompasses the evaluation of novel treatments for managing atherosclerotic cardiovascular disease.
- Lipid Management
- Cardiovascular Risk Reduction
- Cholesterol Control
Diabetes Management
Demonstrates significant expertise in Type 2 Diabetes Mellitus treatment and its complications, including specialized focus on diabetic foot ulcers. The investigator's work extends to exploring innovative therapeutic solutions for diabetes-related wound healing.
- Diabetic Wound Care
- Glycemic Control
- Cardiovascular Outcomes in Diabetes
Metabolic Disorders
Shows dedicated interest in treating metabolic conditions, particularly focusing on obesity and weight management in patients with concurrent metabolic disorders. Their research includes evaluation of therapeutic approaches for complex metabolic conditions.
- Weight Management
- Metabolic Disease Treatment
- Combination Therapy Approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.